LBO-06-Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients
Ma, Xiaoli, Lalezari, Jacob, Nguyen, Tuan, Bae, Ho, Schiff, Eugene R., Fung, Scott, Yuen, Man-Fung, Hassanein, Tarek, Hann, Hie-Won, Elkhashab, Magdy, Dieterich, Douglas, Sulkowski, Mark, Kwo, Paul, NVolume:
70
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0618-8278(19)30230-0
Date:
April, 2019
File:
PDF, 53 KB
english, 2019